Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01211002 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

RADIATION: radiotherapy combined with EP
DRUG: radiotherapy / EP combined with recombinant human endostatin

Sponsor

Simcere Pharmaceutical Co., Ltd

Collaborators

[object Object]